1. Home
  2. IART vs RZLT Comparison

IART vs RZLT Comparison

Compare IART & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IART
  • RZLT
  • Stock Information
  • Founded
  • IART 1989
  • RZLT 2010
  • Country
  • IART United States
  • RZLT United States
  • Employees
  • IART N/A
  • RZLT N/A
  • Industry
  • IART Medical/Dental Instruments
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • IART Health Care
  • RZLT Health Care
  • Exchange
  • IART Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • IART 1.2B
  • RZLT 997.7M
  • IPO Year
  • IART 1995
  • RZLT N/A
  • Fundamental
  • Price
  • IART $12.01
  • RZLT $10.82
  • Analyst Decision
  • IART Hold
  • RZLT Strong Buy
  • Analyst Count
  • IART 7
  • RZLT 6
  • Target Price
  • IART $15.00
  • RZLT $15.33
  • AVG Volume (30 Days)
  • IART 1.3M
  • RZLT 1.5M
  • Earning Date
  • IART 10-30-2025
  • RZLT 11-06-2025
  • Dividend Yield
  • IART N/A
  • RZLT N/A
  • EPS Growth
  • IART N/A
  • RZLT N/A
  • EPS
  • IART N/A
  • RZLT N/A
  • Revenue
  • IART $1,642,966,000.00
  • RZLT N/A
  • Revenue This Year
  • IART $3.51
  • RZLT N/A
  • Revenue Next Year
  • IART $2.88
  • RZLT N/A
  • P/E Ratio
  • IART N/A
  • RZLT N/A
  • Revenue Growth
  • IART 4.99
  • RZLT N/A
  • 52 Week Low
  • IART $10.87
  • RZLT $2.22
  • 52 Week High
  • IART $27.13
  • RZLT $10.94
  • Technical
  • Relative Strength Index (RSI)
  • IART 38.31
  • RZLT 66.73
  • Support Level
  • IART $10.87
  • RZLT $8.55
  • Resistance Level
  • IART $16.42
  • RZLT $10.03
  • Average True Range (ATR)
  • IART 0.87
  • RZLT 0.67
  • MACD
  • IART -0.40
  • RZLT 0.04
  • Stochastic Oscillator
  • IART 20.45
  • RZLT 84.14

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: